| Primary Care Of Bonne Terre | |
|
527 Benham St Bonne Terre MO 63628-1205 | |
| (573) 358-9119 | |
| (573) 358-9489 |
| Full Name | Primary Care Of Bonne Terre |
|---|---|
| Speciality | General Practice |
| Location | 527 Benham St, Bonne Terre, Missouri |
| Authorized Official Name and Position | Andrew J Ninichuck (OWNER) |
| Authorized Official Contact | 5733589119 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Primary Care Of Bonne Terre 527 Benham St Bonne Terre MO 63628-1205 Ph: (573) 358-9119 | Primary Care Of Bonne Terre 527 Benham St Bonne Terre MO 63628-1205 Ph: (573) 358-9119 |
| NPI Number | 1962883751 |
|---|---|
| Provider Enumeration Date | 06/17/2015 |
| Last Update Date | 11/23/2015 |
| Medicare PECOS PAC ID | 4183925415 |
|---|---|
| Medicare Enrollment ID | O20151210001830 |
News Archive
Recently, the researchers had constructed several single molecules with dual hormone action. Now, for the first time, the researchers succeeded in designing a substance that combines three metabolically active hormone components (GLP-1, GIP and glucagon) and offers unmatched potency to fight metabolic diseases in pre-clinical trials.
Researchers at Banner Sun Health Research Institute are about to start the first Phase 2 research study to test a gene transfer agent for Alzheimer's disease. AD is a degenerative and ultimately fatal disorder affecting as many as five million Americans and that number is expected to soar to more than 11 million by 2040.
A paper published in the current issue of Psychotherapy and Psychosomatics, provides a careful analysis of network analysis, a new methodology for understanding psychiatric symptoms.
With "feels-like" temperatures approaching or exceeding 100 degrees forecast for parts of Pennsylvania this week, the Department of Health is reminding all Pennsylvanians of important steps they can take to protect their health.
The continuing COVID-19 pandemic has so far caused 9.58 million cases and more than 488,000 deaths within just six months. The spectrum of disease is broad, from completely asymptomatic cases to critical illness ending in death. Now, a new paper by researchers from Yale University and published on the preprint server medRxiv* in June 2020 identifies an imbalance in immunological response that is linked to poor outcomes and early biomarkers that may help predict the course of the disease.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962883751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | (* (Not Available)) | Primary |
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Secondary |
| Provider Name | Constance Young |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891767125 PECOS PAC ID: 9537168539 Enrollment ID: I20061219000585 |
News Archive
Recently, the researchers had constructed several single molecules with dual hormone action. Now, for the first time, the researchers succeeded in designing a substance that combines three metabolically active hormone components (GLP-1, GIP and glucagon) and offers unmatched potency to fight metabolic diseases in pre-clinical trials.
Researchers at Banner Sun Health Research Institute are about to start the first Phase 2 research study to test a gene transfer agent for Alzheimer's disease. AD is a degenerative and ultimately fatal disorder affecting as many as five million Americans and that number is expected to soar to more than 11 million by 2040.
A paper published in the current issue of Psychotherapy and Psychosomatics, provides a careful analysis of network analysis, a new methodology for understanding psychiatric symptoms.
With "feels-like" temperatures approaching or exceeding 100 degrees forecast for parts of Pennsylvania this week, the Department of Health is reminding all Pennsylvanians of important steps they can take to protect their health.
The continuing COVID-19 pandemic has so far caused 9.58 million cases and more than 488,000 deaths within just six months. The spectrum of disease is broad, from completely asymptomatic cases to critical illness ending in death. Now, a new paper by researchers from Yale University and published on the preprint server medRxiv* in June 2020 identifies an imbalance in immunological response that is linked to poor outcomes and early biomarkers that may help predict the course of the disease.
› Verified 3 days ago
| Provider Name | Andrew Ninichuck |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1609841956 PECOS PAC ID: 0749354249 Enrollment ID: I20080731000726 |
News Archive
Recently, the researchers had constructed several single molecules with dual hormone action. Now, for the first time, the researchers succeeded in designing a substance that combines three metabolically active hormone components (GLP-1, GIP and glucagon) and offers unmatched potency to fight metabolic diseases in pre-clinical trials.
Researchers at Banner Sun Health Research Institute are about to start the first Phase 2 research study to test a gene transfer agent for Alzheimer's disease. AD is a degenerative and ultimately fatal disorder affecting as many as five million Americans and that number is expected to soar to more than 11 million by 2040.
A paper published in the current issue of Psychotherapy and Psychosomatics, provides a careful analysis of network analysis, a new methodology for understanding psychiatric symptoms.
With "feels-like" temperatures approaching or exceeding 100 degrees forecast for parts of Pennsylvania this week, the Department of Health is reminding all Pennsylvanians of important steps they can take to protect their health.
The continuing COVID-19 pandemic has so far caused 9.58 million cases and more than 488,000 deaths within just six months. The spectrum of disease is broad, from completely asymptomatic cases to critical illness ending in death. Now, a new paper by researchers from Yale University and published on the preprint server medRxiv* in June 2020 identifies an imbalance in immunological response that is linked to poor outcomes and early biomarkers that may help predict the course of the disease.
› Verified 3 days ago
News Archive
Recently, the researchers had constructed several single molecules with dual hormone action. Now, for the first time, the researchers succeeded in designing a substance that combines three metabolically active hormone components (GLP-1, GIP and glucagon) and offers unmatched potency to fight metabolic diseases in pre-clinical trials.
Researchers at Banner Sun Health Research Institute are about to start the first Phase 2 research study to test a gene transfer agent for Alzheimer's disease. AD is a degenerative and ultimately fatal disorder affecting as many as five million Americans and that number is expected to soar to more than 11 million by 2040.
A paper published in the current issue of Psychotherapy and Psychosomatics, provides a careful analysis of network analysis, a new methodology for understanding psychiatric symptoms.
With "feels-like" temperatures approaching or exceeding 100 degrees forecast for parts of Pennsylvania this week, the Department of Health is reminding all Pennsylvanians of important steps they can take to protect their health.
The continuing COVID-19 pandemic has so far caused 9.58 million cases and more than 488,000 deaths within just six months. The spectrum of disease is broad, from completely asymptomatic cases to critical illness ending in death. Now, a new paper by researchers from Yale University and published on the preprint server medRxiv* in June 2020 identifies an imbalance in immunological response that is linked to poor outcomes and early biomarkers that may help predict the course of the disease.
› Verified 3 days ago
Bonne Terre Health Clinic Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 55 Nesbit Dr, Bonne Terre, MO 63628 Phone: 573-358-3343 Fax: 573-358-5458 | |
Bonne Terre Medical Associates, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 30 N Allen St, Bonne Terre, MO 63628 Phone: 573-358-3343 | |
Bonne Terre Primary Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 55 Nesbit Dr, Bonne Terre, MO 63628 Phone: 573-358-1480 Fax: 573-358-1489 |